Precision Diabetes: The Next Advance in Patient Care
Professor Andrew Hattersley gave the 2022 CPM Annual Lecture on Thursday 26th May. This event took place at the Sheldonian Theatre. Professor Andrew Hattersley is the Professor of Molecular Medicine at the University of Exeter, UK and a practicing consultant diabetologist at the Royal Devon and Exeter hospital. He trained in Medicine at the Universities of Cambridge and Oxford. His postgraduate education was in London, Oxford and Birmingham. Working with Professor Sian Ellard he has taken Exeter from being a centre with no genetics laboratory in 1995 to now being the top international laboratory for monogenic diabetes with over 20,000 referrals from 105 countries. They have discovered 25 genes which when mutated cause monogenic diabetes. Importantly he has gone on from gene discovery to find the best treatment for monogenic diabetes. He has shown that the commonest forms of both familial genetic diabetes and neonatal diabetes can be treated with tablets instead of insulin resulting in better blood sugar control. Recent work has focused on “Precision Diabetes” identifying subgroups in Type 1 and Type 2 diabetes with different treatment responses. He has published over 600 papers with over 90,000 citations, given over 350 national and international lecturers and received many international and national awards for his work including being appointed as a fellow of The Royal Society and being awarded a CBE.